890P Prospective comparison of RECIST and alternative response assessment criteria in the evaluation of metastatic renal cell cancer patients from phase II of the multi-centre randomised STAR trial.
Authors
Kelly-Morland, CZhong, J
Goh, V
Wah, T
Ralph, C
Thistlethwaite, Fiona C
Patel, P
Nathan, P
Eisen, T
Gregory, W
McParland, L
Cool, H
Royle, K
Best, E
Whincup, L
Collinson, F
Brown, J
Affiliation
Imaging Sciences, 4th Floor Rayne Institute St. Thomas’ hospital, King’s College LondonIssue Date
2017-09
Metadata
Show full item recordCitation
890P Prospective comparison of RECIST and alternative response assessment criteria in the evaluation of metastatic renal cell cancer patients from phase II of the multi-centre randomised STAR trial. 2017, 28(suppl_5): Ann OncolJournal
Annals of OncologyDOI
10.1093/annonc/mdx371.044Additional Links
http://academic.oup.com/annonc/article/doi/10.1093/annonc/mdx371.044/4108976/890PProspective-comparison-of-RECIST-andType
Meetings and ProceedingsLanguage
enISSN
0923-75341569-8041
ae974a485f413a2113503eed53cd6c53
10.1093/annonc/mdx371.044